Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mario Milco D'Elios, Gianfranco Del Prete & Amedeo Amedei. (2009) New frontiers in cell-based immunotherapy of cancer. Expert Opinion on Therapeutic Patents 19:5, pages 623-641.
Read now
Read now
Articles from other publishers (29)
Simone A. Minnie & Geoffrey R. Hill. (2020) Immunotherapy of multiple myeloma. Journal of Clinical Investigation 130:4, pages 1565-1575.
Crossref
Crossref
Susanne H. C. Baumeister, Benedetta Rambaldi, Roman M. Shapiro & Rizwan Romee. (2020) Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation. Frontiers in Immunology 11.
Crossref
Crossref
Mei Xia, Danny C. Hesser, Prithwiraj De, Isaac G. Sakala, Charles T. Spencer, Jay S. Kirkwood, Getahun Abate, Delphi Chatterjee, Karen M. Dobos & Daniel F. Hoft. (2016)
A Subset of Protective γ
9
δ
2
T Cells Is Activated by Novel Mycobacterial Glycolipid Components
. Infection and Immunity 84:9, pages 2449-2462.
Crossref
Crossref
Miriam Perlingeiro Beltrame, Mariester Malvezzi, Carmem Bonfim, Dimas Tadeu Covas, Alberto Orfao & Ricardo Pasquini. (2014) Immune reconstitution in patients with Fanconi anemia after allogeneic bone marrow transplantation. Cytotherapy 16:7, pages 976-989.
Crossref
Crossref
Suchita Chaudhry, Cristiana Cairo, Vanessa Venturi & C. David Pauza. (2013) The γδ T-cell receptor repertoire is reconstituted in HIV patients after prolonged antiretroviral therapy. AIDS 27:10, pages 1557-1562.
Crossref
Crossref
Gabrielle M. Siegers, Emeline J. Ribot, Armand Keating & Paula J. Foster. (2012) Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI. Cancer Immunology, Immunotherapy 62:3, pages 571-583.
Crossref
Crossref
Jean-Jacques Fournié, Hélène Sicard, Mary Poupot, Christine Bezombes, Amandine Blanc, François Romagné, Loic Ysebaert & Guy Laurent. (2012) What lessons can be learned from γδ T cell-based cancer immunotherapy trials?. Cellular & Molecular Immunology 10:1, pages 35-41.
Crossref
Crossref
L. Tesarova, I. Koutna, M. Dvorakova & M. Klabusay. (2012) Relative expression of γδ T‐cell receptor gene families detected by RT–PCR and capillary electrophoresis. International Journal of Immunogenetics 39:5, pages 381-388.
Crossref
Crossref
Dalil Hannani, Yuting Ma, Takahiro Yamazaki, Julie Déchanet-Merville, Guido Kroemer & Laurence Zitvogel. (2012) Harnessing γδ T cells in anticancer immunotherapy. Trends in Immunology 33:5, pages 199-206.
Crossref
Crossref
Julien Giron-Michel, Sandy Azzi, Krystel Khawam, Erwan Mortier, Anne Caignard, Aurore Devocelle, Silvano Ferrini, Michela Croce, Hélène François, Lola Lecru, Bernard Charpentier, Salem Chouaib, Bruno Azzarone & Pierre Eid. (2012) Interleukin-15 Plays a Central Role in Human Kidney Physiology and Cancer through the γc Signaling Pathway. PLoS ONE 7:2, pages e31624.
Crossref
Crossref
Aude-Hélène Capietto, Ludovic Martinet & Jean-Jacques Fournié. (2011) How tumors might withstand γδ T-cell attack. Cellular and Molecular Life Sciences 68:14, pages 2433-2442.
Crossref
Crossref
E. Cimini, P. Piacentini, A. Sacchi, C. Gioia, S. Leone, G.M. Lauro, F. Martini & C. Agrati. (2011) Zoledronic Acid Enhances Vδ2 T-Lymphocyte Antitumor Response to Human Glioma Cell Lines. International Journal of Immunopathology and Pharmacology 24:1, pages 139-148.
Crossref
Crossref
Pouneh Dokouhaki, Mei Han, Betty Joe, Ming Li, Michael R. Johnston, Ming-Sound Tsao & Li Zhang. (2010) Adoptive immunotherapy of cancer using ex vivo expanded human γδ T cells: A new approach. Cancer Letters 297:1, pages 126-136.
Crossref
Crossref
Xiaojuan He, Hui Chen, Di Wu, Lianxian Cui & Wei He. (2010) Tandem-epitope peptide: A novel stimulator for γδT cells in tumor immunotherapy. Cancer Letters 288:1, pages 86-93.
Crossref
Crossref
Juliette Desfrançois, Laurent Derré, Murielle Corvaisier, Bernard Le Mével, Véronique Catros, Francine Jotereau & Nadine Gervois. (2009) Increased frequency of nonconventional double positive CD4CD8 αβ T cells in human breast pleural effusions. International Journal of Cancer 125:2, pages 374-380.
Crossref
Crossref
Ludovic Martinet, Rémy Poupot & Jean-Jacques Fournié. (2009) Pitfalls on the roadmap to γδ T cell-based cancer immunotherapies. Immunology Letters 124:1, pages 1-8.
Crossref
Crossref
Takeshi Yuasa, Kiyoshi Sato, Eishi Ashihara, Miki Takeuchi, Shinya Maita, Norihiko Tsuchiya, Tomonori Habuchi, Taira Maekawa & Shinya Kimura. (2008) Intravesical administration of γδ T cells successfully prevents the growth of bladder cancer in the murine model. Cancer Immunology, Immunotherapy 58:4, pages 493-502.
Crossref
Crossref
Aurélie Thedrez, Christelle Harly, Alexis Morice, Samuel Salot, Marc Bonneville & Emmanuel Scotet. (2009) IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy. The Journal of Immunology 182:6, pages 3423-3431.
Crossref
Crossref
Jaafar Bennouna, Emmanuelle Bompas, Eve Marie Neidhardt, Frédéric Rolland, Irène Philip, Céline Galéa, Samuel Salot, Soraya Saiagh, Marie Audrain, Marie Rimbert, Sylvie Lafaye-de Micheaux, Jérôme Tiollier & Sylvie Négrier. (2008) Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Cancer Immunology, Immunotherapy 57:11, pages 1599-1609.
Crossref
Crossref
Andrew M. Hebbeler, Nadia Propp, Cristiana Cairo, Haishan Li, Jean Saville Cummings, Lisa P. Jacobson, Joseph B. Margolick & C. David Pauza. (2008) Failure to restore the Vγ2-Jγ1.2 repertoire in HIV-infected men receiving highly active antiretroviral therapy (HAART). Clinical Immunology 128:3, pages 349-357.
Crossref
Crossref
Brant A. Inman, Xavier Frigola, Kimberley J. Harris, Susan M. Kuntz, Christine M. Lohse, Bradley C. Leibovich & Eugene D. Kwon. (2008) Questionable Relevance of γδ T Lymphocytes in Renal Cell Carcinoma. The Journal of Immunology 180:5, pages 3578-3584.
Crossref
Crossref
Tim Oliver, Tom Powles, Vinod Nargund & Dan Berney. 2008. Clinical Management of Renal Tumors. Clinical Management of Renal Tumors
355
366
.
J-J Kiladjian, P Fenaux & A Caignard. (2007) Defects of immune surveillance offer new insights into the pathophysiology and therapy of myelodysplastic syndromes. Leukemia 21:11, pages 2237-2239.
Crossref
Crossref
Verena Stresing, Florence Daubiné, Ismahène Benzaid, Hannu Mönkkönen & Philippe Clézardin. (2007) Bisphosphonates in cancer therapy. Cancer Letters 257:1, pages 16-35.
Crossref
Crossref
Samuel Salot, Catherine Laplace, Soraya Saïagh, Sylvain Bercegeay, Isabelle Tenaud, Alain Cassidanius, François Romagne, Brigitte Dreno & Jérôme Tiollier. (2007) Large scale expansion of γ9δ2 T lymphocytes: Innacell γδ™ cell therapy product. Journal of Immunological Methods 326:1-2, pages 63-75.
Crossref
Crossref
P. Wrobel, H. Shojaei, B. Schittek, F. Gieseler, B. Wollenberg, H. Kalthoff, D. Kabelitz & D. Wesch. (2007) Lysis of a Broad Range of Epithelial Tumour Cells by Human ?? T Cells: Involvement of NKG2D ligands and T-cell Receptor- versus NKG2D-dependent Recognition. Scandinavian Journal of Immunology 66:2-3, pages 320-328.
Crossref
Crossref
Susann Beetz, Lothar Marischen, Dieter Kabelitz & Daniela Wesch. (2007) Human γδ T cells. Immunologic Research 37:2, pages 97-111.
Crossref
Crossref
Aurélie Thedrez, Caroline Sabourin, Julie Gertner, Marie-Claire Devilder, Sophie Allain-Maillet, Jean-Jacques Fournié, Emmanuel Scotet & Marc Bonneville. (2007) Self/non-self discrimination by human γδ T cells: simple solutions for a complex issue?. Immunological Reviews 215:1, pages 123-135.
Crossref
Crossref
Dieter Kabelitz, Daniela Wesch & Wei He. (2007) Perspectives of γδ T Cells in Tumor Immunology. Cancer Research 67:1, pages 5-8.
Crossref
Crossref